Bellerophon Therapeutics ...

0.01
-0.01 (-47.37%)
At close: Dec 18, 2024, 5:51 PM

Bellerophon Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
n/a n/a n/a n/a n/a n/a n/a
65K 102K 147K 348K 362K 373K 400K
-65K -102K -147K -348K -362K -373K -400K
-22.38M -20.16M -26.28M -17.47M -27.88M -24.6M -23.76M
n/a n/a n/a n/a 378K 184K 95K
-22.25M -19.56M -26.85M -15.07M -2.63M -54.82M -24.25M
-19.83M -17.76M -24.73M -13.27M 2.81M -54.82M -23.81M
6.02M 7.15M 8.39M 6.44M 7.62M 6.75M 7.11M
16.36M 13.02M 17.89M 11.03M 20.26M 17.85M 16.65M
n/a n/a n/a -674K 27.88M 24.6M 23.76M
22.38M 20.16M 26.28M 17.47M 27.88M 24.6M 23.76M
135K 5K 250K n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
22.38M 20.16M 26.28M 17.47M 27.88M 24.6M 23.76M
-2.42M -1.8M -2.13M -1.8M -5.44M 29.85M -438K
9.55M 9.5M 7.8M 4.5M 4.34M 2.6M 1M
9.55M 9.5M 7.8M 4.5M 4.34M 2.6M 1M
-2.08 -1.87 -3.17 -2.95 0.65 -21.11 -23.72
-2.08 -1.87 -3.17 -2.95 0.65 -21.11 -23.72
-22.18M -20.16M -26.71M -14.72M -2.26M -54.45M -23.85M
-22.25M -19.56M -26.85M -15.07M -2.63M -54.82M -24.25M
65K 102K 147K 348K 362K 373K 400K